<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0061">
 <label>61</label>
 <element-citation publication-type="journal" id="sbref0061">
  <person-group person-group-type="author">
   <name>
    <surname>Lutz</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Lazzaro</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Habbeddine</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Schmidt</surname>
    <given-names>KE</given-names>
   </name>
   <name>
    <surname>Baumhof</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Mui</surname>
    <given-names>BL</given-names>
   </name>
  </person-group>
  <article-title>Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines</article-title>
  <source>NPJ Vaccines</source>
  <volume>2</volume>
  <year>2017</year>
  <fpage>29</fpage>
  <pub-id pub-id-type="pmid">29263884</pub-id>
 </element-citation>
</ref>
